CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants
Andrew D. Redd(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Evan M. Bloch(Johns Hopkins University), Alessandra Nardin(Singapore Immunology Network), Andrew Pekosz(Johns Hopkins University), Hassen Kared(Singapore Immunology Network), Oliver Laeyendecker(Johns Hopkins University), Michael Fehlings(University of Toronto), Thomas C. Quinn(Johns Hopkins University)
Cited by 107
Related Papers
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k
The Natural History of Hepatitis C Virus Infection
|JAMA|2000|1.1k
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
A Literature Review of Zika Virus
|Emerging infectious diseases|2016|615